David G. Maloney

Dec 04, 2018

CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018

Dec 02, 2018

Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2 Clinical Trials in B cell Malignancies at the 60th ASH Annual Meeting

Nov 02, 2018

Autolus Therapeutics to Present New Data at the ASH Annual Meeting

Nov 01, 2018

Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 60th ASH Annual Meeting

Aug 03, 2018

CAR T Cell Therapy Market Global Trends, Growth Drivers, Targeted Antigens Opportunities and Forecast to 2028

Jul 30, 2018

Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

Feb 07, 2018

CAR-T Cell Immunotherapy Clinical Trial Cancer Patient in Remission; First-in-the-World Cancer Treatment Shows Promise

Dec 13, 2017

ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

Dec 10, 2017

CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma

Nov 03, 2017

Global CAR T-cell Therapy for Multiple Myeloma Pipeline Analysis Report 2017

Aug 29, 2017

ARMO BioSciences Raises $67 Million in a Series C-1 Financing

Aug 17, 2017

ViraCyte Awarded $8.99M from the Cancer Prevention and Research Institute of Texas